Ledipasvir/sofosbuvir and ribavirin for the treatment of ribavirin-refractory persistent hepatitis E virus infection

Persistent Hepatitis E Virus infection (HEV) is a rare but increasingly recognised condition in immunocompromised individuals. Untreated, this infection can rapidly progress to cirrhosis. Ribavirin is recommended as the first line treatment and the majority achieve sustained viral clearance. However...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Jennifer Gallacher, Yusri Taha, Ana da Silva Filipe, Samreen Ijaz, Stuart McPherson
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2023-01-01
Edice:	IDCases
Témata:	Hepatitis E virus Treatment Antiviral resistance Chronic infection Immunosuppressed
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2214250923000653
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!